nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—CA5B—cervicothoracic ganglion—systemic scleroderma	0.17	0.427	CbGeAlD
Hydroflumethiazide—KCNMA1—pulmonary artery—systemic scleroderma	0.0543	0.137	CbGeAlD
Hydroflumethiazide—Vasculitis necrotising—Leflunomide—systemic scleroderma	0.0286	0.0474	CcSEcCtD
Hydroflumethiazide—KCNMA1—artery—systemic scleroderma	0.0201	0.0506	CbGeAlD
Hydroflumethiazide—Gastric irritation—Captopril—systemic scleroderma	0.0187	0.0311	CcSEcCtD
Hydroflumethiazide—Angiitis necrotising—Prednisone—systemic scleroderma	0.0167	0.0278	CcSEcCtD
Hydroflumethiazide—KCNMA1—blood vessel—systemic scleroderma	0.0157	0.0394	CbGeAlD
Hydroflumethiazide—Vasculitis necrotising—Prednisone—systemic scleroderma	0.0146	0.0242	CcSEcCtD
Hydroflumethiazide—Epigastric discomfort—Captopril—systemic scleroderma	0.0138	0.0229	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.009	0.0149	CcSEcCtD
Hydroflumethiazide—CA7—digestive system—systemic scleroderma	0.00857	0.0215	CbGeAlD
Hydroflumethiazide—Jaundice cholestatic—Captopril—systemic scleroderma	0.00827	0.0137	CcSEcCtD
Hydroflumethiazide—Gastric irritation—Prednisone—systemic scleroderma	0.00788	0.0131	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Pentoxifylline—systemic scleroderma	0.00778	0.0129	CcSEcCtD
Hydroflumethiazide—CA12—connective tissue—systemic scleroderma	0.0077	0.0194	CbGeAlD
Hydroflumethiazide—CA9—digestive system—systemic scleroderma	0.00752	0.0189	CbGeAlD
Hydroflumethiazide—Vasculitis—Captopril—systemic scleroderma	0.00744	0.0124	CcSEcCtD
Hydroflumethiazide—KCNMA1—smooth muscle tissue—systemic scleroderma	0.00735	0.0185	CbGeAlD
Hydroflumethiazide—Purpura—Pentoxifylline—systemic scleroderma	0.00722	0.012	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Azathioprine—systemic scleroderma	0.00722	0.012	CcSEcCtD
Hydroflumethiazide—CA9—tendon—systemic scleroderma	0.00716	0.018	CbGeAlD
Hydroflumethiazide—SLC12A3—lung—systemic scleroderma	0.00701	0.0176	CbGeAlD
Hydroflumethiazide—CA14—tendon—systemic scleroderma	0.00679	0.0171	CbGeAlD
Hydroflumethiazide—Jaundice cholestatic—Mycophenolic acid—systemic scleroderma	0.0065	0.0108	CcSEcCtD
Hydroflumethiazide—Vasculitis—Azathioprine—systemic scleroderma	0.0065	0.0108	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Mycophenolic acid—systemic scleroderma	0.00616	0.0102	CcSEcCtD
Hydroflumethiazide—Vasculitis—Leflunomide—systemic scleroderma	0.00613	0.0102	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Captopril—systemic scleroderma	0.00601	0.00997	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00595	0.00988	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Lisinopril—systemic scleroderma	0.00586	0.00972	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Mycophenolic acid—systemic scleroderma	0.00582	0.00965	CcSEcCtD
Hydroflumethiazide—Epigastric discomfort—Prednisone—systemic scleroderma	0.00581	0.00964	CcSEcCtD
Hydroflumethiazide—CA12—digestive system—systemic scleroderma	0.00556	0.014	CbGeAlD
Hydroflumethiazide—Vasculitis—Lisinopril—systemic scleroderma	0.00527	0.00875	CcSEcCtD
Hydroflumethiazide—Jaundice—Pentoxifylline—systemic scleroderma	0.00523	0.00868	CcSEcCtD
Hydroflumethiazide—ATP1A1—connective tissue—systemic scleroderma	0.00516	0.013	CbGeAlD
Hydroflumethiazide—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.00513	0.00851	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Mycophenolate mofetil—systemic scleroderma	0.00486	0.00806	CcSEcCtD
Hydroflumethiazide—KCNMA1—lung—systemic scleroderma	0.00485	0.0122	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Captopril—systemic scleroderma	0.00482	0.00799	CcSEcCtD
Hydroflumethiazide—CA5B—tendon—systemic scleroderma	0.00475	0.012	CbGeAlD
Hydroflumethiazide—ATP1A1—smooth muscle tissue—systemic scleroderma	0.00472	0.0119	CbGeAlD
Hydroflumethiazide—ATP1A1—skin of body—systemic scleroderma	0.00466	0.0117	CbGeAlD
Hydroflumethiazide—CA12—lung—systemic scleroderma	0.00465	0.0117	CbGeAlD
Hydroflumethiazide—Blood uric acid increased—Mycophenolate mofetil—systemic scleroderma	0.00459	0.00762	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Captopril—systemic scleroderma	0.00447	0.00742	CcSEcCtD
Hydroflumethiazide—CA1—digestive system—systemic scleroderma	0.00441	0.0111	CbGeAlD
Hydroflumethiazide—Photosensitivity—Lisinopril—systemic scleroderma	0.00425	0.00706	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00423	0.00702	CcSEcCtD
Hydroflumethiazide—CA5B—lung—systemic scleroderma	0.00417	0.0105	CbGeAlD
Hydroflumethiazide—Photosensitivity reaction—Captopril—systemic scleroderma	0.00416	0.0069	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Pentoxifylline—systemic scleroderma	0.00403	0.00669	CcSEcCtD
Hydroflumethiazide—Jaundice—Captopril—systemic scleroderma	0.00396	0.00657	CcSEcCtD
Hydroflumethiazide—CA2—connective tissue—systemic scleroderma	0.00396	0.00995	CbGeAlD
Hydroflumethiazide—Cramp muscle—Leflunomide—systemic scleroderma	0.00391	0.0065	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Azathioprine—systemic scleroderma	0.0039	0.00647	CcSEcCtD
Hydroflumethiazide—Agitation—Pentoxifylline—systemic scleroderma	0.00385	0.00639	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Captopril—systemic scleroderma	0.00379	0.00629	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00379	0.00629	CcSEcCtD
Hydroflumethiazide—Glycosuria—Prednisone—systemic scleroderma	0.00377	0.00626	CcSEcCtD
Hydroflumethiazide—Leukopenia—Pentoxifylline—systemic scleroderma	0.00375	0.00623	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Mycophenolic acid—systemic scleroderma	0.00373	0.0062	CcSEcCtD
Hydroflumethiazide—ATP1A1—digestive system—systemic scleroderma	0.00373	0.00938	CbGeAlD
Hydroflumethiazide—Pancreatitis—Leflunomide—systemic scleroderma	0.00368	0.00611	CcSEcCtD
Hydroflumethiazide—CA1—lung—systemic scleroderma	0.00368	0.00926	CbGeAlD
Hydroflumethiazide—CA2—smooth muscle tissue—systemic scleroderma	0.00362	0.0091	CbGeAlD
Hydroflumethiazide—CA2—skin of body—systemic scleroderma	0.00357	0.00899	CbGeAlD
Hydroflumethiazide—ATP1A1—tendon—systemic scleroderma	0.00355	0.00893	CbGeAlD
Hydroflumethiazide—Pancreatitis—Mycophenolic acid—systemic scleroderma	0.00351	0.00583	CcSEcCtD
Hydroflumethiazide—CA4—digestive system—systemic scleroderma	0.00345	0.00867	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00341	0.00566	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Leflunomide—systemic scleroderma	0.00339	0.00562	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Lisinopril—systemic scleroderma	0.00336	0.00558	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00335	0.00556	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Azathioprine—systemic scleroderma	0.00331	0.00549	CcSEcCtD
Hydroflumethiazide—CA4—tendon—systemic scleroderma	0.00328	0.00825	CbGeAlD
Hydroflumethiazide—Jaundice—Leflunomide—systemic scleroderma	0.00326	0.00542	CcSEcCtD
Hydroflumethiazide—Anorexia—Pentoxifylline—systemic scleroderma	0.00326	0.00541	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00323	0.00537	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Lisinopril—systemic scleroderma	0.00316	0.00525	CcSEcCtD
Hydroflumethiazide—Vasculitis—Prednisone—systemic scleroderma	0.00313	0.0052	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Leflunomide—systemic scleroderma	0.00313	0.00519	CcSEcCtD
Hydroflumethiazide—Jaundice—Mycophenolic acid—systemic scleroderma	0.00311	0.00517	CcSEcCtD
Hydroflumethiazide—ATP1A1—lung—systemic scleroderma	0.00311	0.00783	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00299	0.00496	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00298	0.00495	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00297	0.00493	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00295	0.00489	CcSEcCtD
Hydroflumethiazide—Constipation—Pentoxifylline—systemic scleroderma	0.00292	0.00485	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00291	0.00483	CcSEcCtD
Hydroflumethiazide—CA4—lung—systemic scleroderma	0.00288	0.00724	CbGeAlD
Hydroflumethiazide—CA2—digestive system—systemic scleroderma	0.00286	0.00719	CbGeAlD
Hydroflumethiazide—Anorexia—Mometasone—systemic scleroderma	0.00281	0.00467	CcSEcCtD
Hydroflumethiazide—Jaundice—Lisinopril—systemic scleroderma	0.00281	0.00466	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.00277	0.0046	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Methotrexate—systemic scleroderma	0.00275	0.00457	CcSEcCtD
Hydroflumethiazide—CA2—tendon—systemic scleroderma	0.00272	0.00684	CbGeAlD
Hydroflumethiazide—Urticaria—Pentoxifylline—systemic scleroderma	0.00272	0.00451	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Lisinopril—systemic scleroderma	0.00269	0.00446	CcSEcCtD
Hydroflumethiazide—Vasculitis—Methotrexate—systemic scleroderma	0.00262	0.00434	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Methotrexate—systemic scleroderma	0.0026	0.00432	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Mometasone—systemic scleroderma	0.00257	0.00426	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00255	0.00423	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Captopril—systemic scleroderma	0.00254	0.00421	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00252	0.00418	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Leflunomide—systemic scleroderma	0.00252	0.00418	CcSEcCtD
Hydroflumethiazide—Leukopenia—Azathioprine—systemic scleroderma	0.00248	0.00412	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Prednisone—systemic scleroderma	0.00248	0.00412	CcSEcCtD
Hydroflumethiazide—Anorexia—Captopril—systemic scleroderma	0.00247	0.0041	CcSEcCtD
Hydroflumethiazide—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00246	0.00408	CcSEcCtD
Hydroflumethiazide—Asthenia—Pentoxifylline—systemic scleroderma	0.00245	0.00407	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.0024	0.00398	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Methotrexate—systemic scleroderma	0.0024	0.00398	CcSEcCtD
Hydroflumethiazide—CA2—lung—systemic scleroderma	0.00239	0.006	CbGeAlD
Hydroflumethiazide—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00391	CcSEcCtD
Hydroflumethiazide—Vertigo—Leflunomide—systemic scleroderma	0.00235	0.0039	CcSEcCtD
Hydroflumethiazide—Leukopenia—Leflunomide—systemic scleroderma	0.00234	0.00389	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00234	0.00388	CcSEcCtD
Hydroflumethiazide—Purpura—Prednisone—systemic scleroderma	0.0023	0.00382	CcSEcCtD
Hydroflumethiazide—Agitation—Mycophenolic acid—systemic scleroderma	0.00229	0.00381	CcSEcCtD
Hydroflumethiazide—Dizziness—Pentoxifylline—systemic scleroderma	0.00226	0.00375	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Captopril—systemic scleroderma	0.00225	0.00374	CcSEcCtD
Hydroflumethiazide—Vertigo—Mycophenolic acid—systemic scleroderma	0.00224	0.00372	CcSEcCtD
Hydroflumethiazide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00223	0.00371	CcSEcCtD
Hydroflumethiazide—Constipation—Captopril—systemic scleroderma	0.00222	0.00368	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00221	0.00368	CcSEcCtD
Hydroflumethiazide—Vomiting—Pentoxifylline—systemic scleroderma	0.00217	0.00361	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Lisinopril—systemic scleroderma	0.00216	0.00359	CcSEcCtD
Hydroflumethiazide—Rash—Pentoxifylline—systemic scleroderma	0.00216	0.00358	CcSEcCtD
Hydroflumethiazide—Dermatitis—Pentoxifylline—systemic scleroderma	0.00215	0.00358	CcSEcCtD
Hydroflumethiazide—Headache—Pentoxifylline—systemic scleroderma	0.00214	0.00356	CcSEcCtD
Hydroflumethiazide—Asthenia—Mometasone—systemic scleroderma	0.00212	0.00351	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Methotrexate—systemic scleroderma	0.00211	0.0035	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00209	0.00347	CcSEcCtD
Hydroflumethiazide—Anorexia—Leflunomide—systemic scleroderma	0.00204	0.00338	CcSEcCtD
Hydroflumethiazide—Nausea—Pentoxifylline—systemic scleroderma	0.00203	0.00337	CcSEcCtD
Hydroflumethiazide—Vertigo—Lisinopril—systemic scleroderma	0.00202	0.00335	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Mometasone—systemic scleroderma	0.00202	0.00335	CcSEcCtD
Hydroflumethiazide—Leukopenia—Lisinopril—systemic scleroderma	0.00201	0.00334	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.002	0.00331	CcSEcCtD
Hydroflumethiazide—Anorexia—Mycophenolic acid—systemic scleroderma	0.00194	0.00322	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00314	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Prednisone—systemic scleroderma	0.00188	0.00312	CcSEcCtD
Hydroflumethiazide—Vomiting—Mometasone—systemic scleroderma	0.00188	0.00311	CcSEcCtD
Hydroflumethiazide—Rash—Mometasone—systemic scleroderma	0.00186	0.00309	CcSEcCtD
Hydroflumethiazide—Asthenia—Captopril—systemic scleroderma	0.00186	0.00309	CcSEcCtD
Hydroflumethiazide—Dermatitis—Mometasone—systemic scleroderma	0.00186	0.00309	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Leflunomide—systemic scleroderma	0.00186	0.00308	CcSEcCtD
Hydroflumethiazide—Headache—Mometasone—systemic scleroderma	0.00185	0.00307	CcSEcCtD
Hydroflumethiazide—Constipation—Leflunomide—systemic scleroderma	0.00183	0.00303	CcSEcCtD
Hydroflumethiazide—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00301	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.0018	0.00298	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Captopril—systemic scleroderma	0.00177	0.00294	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00177	0.00294	CcSEcCtD
Hydroflumethiazide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00294	CcSEcCtD
Hydroflumethiazide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00293	CcSEcCtD
Hydroflumethiazide—Nausea—Mometasone—systemic scleroderma	0.00175	0.00291	CcSEcCtD
Hydroflumethiazide—Anorexia—Lisinopril—systemic scleroderma	0.00175	0.0029	CcSEcCtD
Hydroflumethiazide—Constipation—Mycophenolic acid—systemic scleroderma	0.00174	0.00289	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Prednisone—systemic scleroderma	0.00173	0.00287	CcSEcCtD
Hydroflumethiazide—Dizziness—Captopril—systemic scleroderma	0.00171	0.00284	CcSEcCtD
Hydroflumethiazide—Urticaria—Leflunomide—systemic scleroderma	0.0017	0.00282	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Azathioprine—systemic scleroderma	0.00167	0.00277	CcSEcCtD
Hydroflumethiazide—Vomiting—Captopril—systemic scleroderma	0.00165	0.00274	CcSEcCtD
Hydroflumethiazide—Rash—Captopril—systemic scleroderma	0.00163	0.00271	CcSEcCtD
Hydroflumethiazide—Dermatitis—Captopril—systemic scleroderma	0.00163	0.00271	CcSEcCtD
Hydroflumethiazide—Headache—Captopril—systemic scleroderma	0.00162	0.00269	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Lisinopril—systemic scleroderma	0.0016	0.00265	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00261	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Leflunomide—systemic scleroderma	0.00157	0.00261	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Methotrexate—systemic scleroderma	0.00157	0.00261	CcSEcCtD
Hydroflumethiazide—Constipation—Lisinopril—systemic scleroderma	0.00157	0.00261	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Azathioprine—systemic scleroderma	0.00155	0.00257	CcSEcCtD
Hydroflumethiazide—Nausea—Captopril—systemic scleroderma	0.00154	0.00256	CcSEcCtD
Hydroflumethiazide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00254	CcSEcCtD
Hydroflumethiazide—Asthenia—Leflunomide—systemic scleroderma	0.00153	0.00254	CcSEcCtD
Hydroflumethiazide—Dizziness—Azathioprine—systemic scleroderma	0.0015	0.00248	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00146	0.00243	CcSEcCtD
Hydroflumethiazide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00146	0.00243	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Leflunomide—systemic scleroderma	0.00146	0.00243	CcSEcCtD
Hydroflumethiazide—Urticaria—Lisinopril—systemic scleroderma	0.00146	0.00242	CcSEcCtD
Hydroflumethiazide—Vomiting—Azathioprine—systemic scleroderma	0.00144	0.00239	CcSEcCtD
Hydroflumethiazide—Rash—Azathioprine—systemic scleroderma	0.00143	0.00237	CcSEcCtD
Hydroflumethiazide—Dermatitis—Azathioprine—systemic scleroderma	0.00142	0.00236	CcSEcCtD
Hydroflumethiazide—Headache—Azathioprine—systemic scleroderma	0.00142	0.00235	CcSEcCtD
Hydroflumethiazide—Dizziness—Leflunomide—systemic scleroderma	0.00141	0.00234	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00232	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00139	0.00231	CcSEcCtD
Hydroflumethiazide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00228	CcSEcCtD
Hydroflumethiazide—Vomiting—Leflunomide—systemic scleroderma	0.00136	0.00225	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Lisinopril—systemic scleroderma	0.00135	0.00224	CcSEcCtD
Hydroflumethiazide—Dizziness—Mycophenolic acid—systemic scleroderma	0.00135	0.00224	CcSEcCtD
Hydroflumethiazide—Rash—Leflunomide—systemic scleroderma	0.00135	0.00224	CcSEcCtD
Hydroflumethiazide—Dermatitis—Leflunomide—systemic scleroderma	0.00135	0.00223	CcSEcCtD
Hydroflumethiazide—Nausea—Azathioprine—systemic scleroderma	0.00134	0.00223	CcSEcCtD
Hydroflumethiazide—Headache—Leflunomide—systemic scleroderma	0.00134	0.00222	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Methotrexate—systemic scleroderma	0.00133	0.00221	CcSEcCtD
Hydroflumethiazide—Asthenia—Lisinopril—systemic scleroderma	0.00132	0.00219	CcSEcCtD
Hydroflumethiazide—Vomiting—Mycophenolic acid—systemic scleroderma	0.0013	0.00215	CcSEcCtD
Hydroflumethiazide—Rash—Mycophenolic acid—systemic scleroderma	0.00128	0.00213	CcSEcCtD
Hydroflumethiazide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00128	0.00213	CcSEcCtD
Hydroflumethiazide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00212	CcSEcCtD
Hydroflumethiazide—Headache—Mycophenolic acid—systemic scleroderma	0.00128	0.00212	CcSEcCtD
Hydroflumethiazide—Nausea—Leflunomide—systemic scleroderma	0.00127	0.00211	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Lisinopril—systemic scleroderma	0.00126	0.00208	CcSEcCtD
Hydroflumethiazide—Agitation—Prednisone—systemic scleroderma	0.00123	0.00204	CcSEcCtD
Hydroflumethiazide—Dizziness—Lisinopril—systemic scleroderma	0.00121	0.00201	CcSEcCtD
Hydroflumethiazide—Nausea—Mycophenolic acid—systemic scleroderma	0.00121	0.00201	CcSEcCtD
Hydroflumethiazide—Vertigo—Prednisone—systemic scleroderma	0.0012	0.00199	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00197	CcSEcCtD
Hydroflumethiazide—Vomiting—Lisinopril—systemic scleroderma	0.00117	0.00194	CcSEcCtD
Hydroflumethiazide—Rash—Lisinopril—systemic scleroderma	0.00116	0.00192	CcSEcCtD
Hydroflumethiazide—Dermatitis—Lisinopril—systemic scleroderma	0.00116	0.00192	CcSEcCtD
Hydroflumethiazide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00192	CcSEcCtD
Hydroflumethiazide—Headache—Lisinopril—systemic scleroderma	0.00115	0.00191	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00183	CcSEcCtD
Hydroflumethiazide—Nausea—Lisinopril—systemic scleroderma	0.00109	0.00181	CcSEcCtD
Hydroflumethiazide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00177	CcSEcCtD
Hydroflumethiazide—Anorexia—Prednisone—systemic scleroderma	0.00104	0.00172	CcSEcCtD
Hydroflumethiazide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00102	0.0017	CcSEcCtD
Hydroflumethiazide—Rash—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00168	CcSEcCtD
Hydroflumethiazide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00168	CcSEcCtD
Hydroflumethiazide—Headache—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00167	CcSEcCtD
Hydroflumethiazide—Vertigo—Methotrexate—systemic scleroderma	0.001	0.00166	CcSEcCtD
Hydroflumethiazide—Leukopenia—Methotrexate—systemic scleroderma	0.000999	0.00166	CcSEcCtD
Hydroflumethiazide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000955	0.00159	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Prednisone—systemic scleroderma	0.000948	0.00157	CcSEcCtD
Hydroflumethiazide—Constipation—Prednisone—systemic scleroderma	0.000932	0.00155	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000892	0.00148	CcSEcCtD
Hydroflumethiazide—Anorexia—Methotrexate—systemic scleroderma	0.000868	0.00144	CcSEcCtD
Hydroflumethiazide—Urticaria—Prednisone—systemic scleroderma	0.000866	0.00144	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Prednisone—systemic scleroderma	0.000803	0.00133	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Methotrexate—systemic scleroderma	0.000792	0.00131	CcSEcCtD
Hydroflumethiazide—Asthenia—Prednisone—systemic scleroderma	0.000782	0.0013	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Prednisone—systemic scleroderma	0.000746	0.00124	CcSEcCtD
Hydroflumethiazide—Urticaria—Methotrexate—systemic scleroderma	0.000724	0.0012	CcSEcCtD
Hydroflumethiazide—Dizziness—Prednisone—systemic scleroderma	0.000721	0.0012	CcSEcCtD
Hydroflumethiazide—Vomiting—Prednisone—systemic scleroderma	0.000693	0.00115	CcSEcCtD
Hydroflumethiazide—Rash—Prednisone—systemic scleroderma	0.000687	0.00114	CcSEcCtD
Hydroflumethiazide—Dermatitis—Prednisone—systemic scleroderma	0.000687	0.00114	CcSEcCtD
Hydroflumethiazide—Headache—Prednisone—systemic scleroderma	0.000683	0.00113	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Methotrexate—systemic scleroderma	0.000671	0.00111	CcSEcCtD
Hydroflumethiazide—Asthenia—Methotrexate—systemic scleroderma	0.000654	0.00108	CcSEcCtD
Hydroflumethiazide—Nausea—Prednisone—systemic scleroderma	0.000648	0.00107	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Methotrexate—systemic scleroderma	0.000623	0.00103	CcSEcCtD
Hydroflumethiazide—Dizziness—Methotrexate—systemic scleroderma	0.000602	0.001	CcSEcCtD
Hydroflumethiazide—Vomiting—Methotrexate—systemic scleroderma	0.000579	0.000961	CcSEcCtD
Hydroflumethiazide—Rash—Methotrexate—systemic scleroderma	0.000574	0.000953	CcSEcCtD
Hydroflumethiazide—Dermatitis—Methotrexate—systemic scleroderma	0.000574	0.000953	CcSEcCtD
Hydroflumethiazide—Headache—Methotrexate—systemic scleroderma	0.000571	0.000947	CcSEcCtD
Hydroflumethiazide—Nausea—Methotrexate—systemic scleroderma	0.000541	0.000898	CcSEcCtD
